Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00910559 · ClinicalTrials.gov registry record

Phenotypic and Genetic Factors in Autism Spectrum Disorders

A clinical trial of Autism Spectrum Disorders, sponsored by Boston Children's Hospital.

Active
Registry status
1,500
Enrollment target
1
Study location

NCT00910559 is a study of Autism Spectrum Disorders that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 1,500 participants, above the 93-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (1513% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00910559, a study of Autism Spectrum Disorders, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.

Conditions Studied

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2008-07
Est. Completion 2030-02

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00910559

The ClinicalTrials.gov registry entry for NCT00910559 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 93-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (1513% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00910559 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00910559 about?

NCT00910559 is a clinical study titled "Phenotypic and Genetic Factors in Autism Spectrum Disorders". The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.

What is the current status of trial NCT00910559?

This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2008-07. Estimated completion is 2030-02.

What conditions does trial NCT00910559 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

Who is sponsoring clinical trial NCT00910559?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00910559 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.